• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Does tamoxifen have a negative effect on survival chances of premenopausal women with locoregional recurrence of breast carcinoma?].

作者信息

Sauer H

出版信息

Strahlenther Onkol. 1997 Jul;173(7):390. doi: 10.1007/BF03038245.

DOI:10.1007/BF03038245
PMID:9265263
Abstract
摘要

相似文献

1
[Does tamoxifen have a negative effect on survival chances of premenopausal women with locoregional recurrence of breast carcinoma?].
Strahlenther Onkol. 1997 Jul;173(7):390. doi: 10.1007/BF03038245.
2
Possible deleterious effect of tamoxifen in premenopausal women with locoregional recurrence of breast cancer.他莫昔芬对局部区域复发的绝经前乳腺癌女性可能产生的有害影响。
Eur J Cancer. 1996 Nov;32A(12):2173-6. doi: 10.1016/s0959-8049(96)00227-4.
3
Optimal systemic therapy for premenopausal women with hormone receptor-positive breast cancer.绝经前激素受体阳性乳腺癌的最佳全身治疗。
Breast. 2013 Aug;22 Suppl 2:S165-70. doi: 10.1016/j.breast.2013.07.032.
4
Exacerbation of endometriosis as a result of premenopausal tamoxifen exposure.绝经前接触他莫昔芬导致子宫内膜异位症恶化。
Am J Obstet Gynecol. 2000 Aug;183(2):507-8. doi: 10.1067/mob.2000.105966.
5
Caring for the breast cancer survivor.关爱乳腺癌幸存者。
Am J Med. 2011 Feb;124(2):e11; author reply e13. doi: 10.1016/j.amjmed.2010.08.016.
6
New Insights Into Nonadherence With Adjuvant Endocrine Therapy Among Young Women With Breast Cancer.年轻乳腺癌女性辅助内分泌治疗依从性差的新见解
J Natl Cancer Inst. 2015 Aug 25;107(10). doi: 10.1093/jnci/djv245. Print 2015 Oct.
7
Acute abdomen due to endometriosis in a premenopausal woman taking tamoxifen.
Eur J Obstet Gynecol Reprod Biol. 2003 Aug 15;109(2):234-5. doi: 10.1016/s0301-2115(03)00004-6.
8
Survival Outcome of Combined GnRH Agonist and Tamoxifen Is Comparable to That of Sequential Adriamycin and Cyclophosphamide Chemotherapy Plus Tamoxifen in Premenopausal Patients with Lymph-Node-Negative, Hormone-Responsive, HER2-Negative, T1-T2 Breast Cancer.对于淋巴结阴性、激素受体阳性、HER2 阴性、T1-T2 期的绝经前乳腺癌患者，促性腺激素释放激素激动剂联合他莫昔芬的生存结局与序贯阿霉素和环磷酰胺化疗联合他莫昔芬相当。
Cancer Res Treat. 2016 Oct;48(4):1351-1362. doi: 10.4143/crt.2015.444. Epub 2016 Apr 6.
9
Navigating the Challenges of Endocrine Treatments in Premenopausal Women with ER-Positive Early Breast Cancer.绝经前雌激素受体阳性早期乳腺癌患者内分泌治疗的挑战及应对
Drugs. 2015 Aug;75(12):1311-21. doi: 10.1007/s40265-015-0433-7.
10
Controversies in the management of patients with breast cancer: adjuvant endocrine therapy in premenopausal women.乳腺癌患者管理中的争议：绝经前女性的辅助内分泌治疗
J Clin Oncol. 2008 Feb 10;26(5):745-52. doi: 10.1200/JCO.2007.14.3016.

本文引用的文献

1
Possible deleterious effect of tamoxifen in premenopausal women with locoregional recurrence of breast cancer.他莫昔芬对局部区域复发的绝经前乳腺癌女性可能产生的有害影响。
Eur J Cancer. 1996 Nov;32A(12):2173-6. doi: 10.1016/s0959-8049(96)00227-4.
2
First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation. Swiss Group for Clinical Cancer Research.乳腺癌乳房切除术后首次孤立性局部区域复发：一项III期多中心研究结果，比较切除及放疗后全身治疗与观察。瑞士临床癌症研究组。
J Clin Oncol. 1994 Oct;12(10):2071-7. doi: 10.1200/JCO.1994.12.10.2071.